{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T06:34:14Z","timestamp":1697870054394},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/aci.0000000000000076","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T12:48:13Z","timestamp":1402058893000},"page":"301-306","source":"Crossref","is-referenced-by-count":6,"title":["The study of severe cutaneous drug hypersensitivity reactions from a systems biology perspective"],"prefix":"10.1097","volume":"14","author":[{"given":"James R.","family":"Perkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Ayuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Cornejo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Ranea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jdermsci.2012.04.002","article-title":"Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.","volume":"66","author":"Chung","year":"2012","journal-title":"J Dermatol Sci"},{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification.","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs.","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/ACI.0b013e3283630cc2","article-title":"Toxic epidermal necrolysis: the year in review.","volume":"13","author":"Lee","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.","volume":"128","author":"Ko","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archderm.140.2.242","article-title":"Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis.","volume":"140","author":"Chang","year":"2004","journal-title":"Arch Dermatol"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2002.120563","article-title":"Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity.","volume":"109","author":"Posadas","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","article-title":"Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome.","volume":"151","author":"Abe","year":"2009","journal-title":"Ann Intern Med"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2133.2009.09627.x","article-title":"Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.","volume":"162","author":"Bellon","year":"2010","journal-title":"Br J Dermatol"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/ACI.0b013e3283489c2c","article-title":"The innate immune system in delayed cutaneous allergic reactions to medications.","volume":"11","author":"Bellon","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.","volume":"47","author":"Correia","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis.","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","article-title":"Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrometoxic epidermal necrolysis.","volume":"155","author":"Caproni","year":"2006","journal-title":"Br J Dermatol"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2004.04.034","article-title":"Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.","volume":"114","author":"Tapia","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis.","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome.","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R26-7-20210128","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R27-7-20210128","first-page":"550","article-title":"HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese.","volume":"14","author":"Ueta","year":"2008","journal-title":"Mol Vis"},{"key":"R28-7-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens-Johnson syndrome ...: ethnicity matters.","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-7-20210128","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genom"},{"key":"R31-7-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":"Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.","volume":"21","author":"Kang","year":"2011","journal-title":"Pharmacogenet Genom"},{"key":"R32-7-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genom"},{"key":"R33-7-20210128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/tpj.2011.41","article-title":"A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.","volume":"13","author":"Tohkin","year":"2013","journal-title":"Pharmacogenom J"},{"key":"R34-7-20210128","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/591184","article-title":"The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.","volume":"198","author":"Colombo","year":"2008","journal-title":"J Infect Dis"},{"key":"R35-7-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2133\/dmpk.DMPK-11-NT-120","article-title":"Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrometoxic epidermal necrolysis in Japanese.","volume":"27","author":"Maekawa","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"R36-7-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ACI.0b013e3283079c64","article-title":"The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity.","volume":"8","author":"Lavergne","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R37-7-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: the p-i concept.","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol Int"},{"key":"R38-7-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(02)00255-X","article-title":"The danger hypothesis: potential role in idiosyncratic drug reactions.","volume":"181-","author":"Pirmohamed","year":"2002","journal-title":"Toxicology"},{"key":"R39-7-20210128","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8 T cells provides the immunogenetic basis of a systemic drug hypersensitivity.","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"R40-7-20210128","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"R41-7-20210128","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-7-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0b013e318046ea31","article-title":"Prospective screening for human leukocyte antigen-B5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population.","volume":"45","author":"Zucman","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R43-7-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10408360902937817","article-title":"HLA-B5701 screening prior to abacavir prescription: clinical and laboratory aspects.","volume":"46","author":"Nolan","year":"2009","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R44-7-20210128","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.eimc.2009.09.010","article-title":"Cost-effectiveness analysis of HLA-B5701 typing in the prevention of hypersensitivity to abacavir in HIV patients in Spain.","volume":"28","author":"Nieves Calatrava","year":"2010","journal-title":"Enfermedades Infecc Microbiol Clin"},{"key":"R45-7-20210128","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B5701 screening for hypersensitivity to abacavir.","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"R46-7-20210128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-6-52","article-title":"Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe.","volume":"6","author":"Genin","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R47-7-20210128","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A3101 and carbamazepine-induced hypersensitivity reactions in Europeans.","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"R48-7-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/tpj.2010.84","article-title":"Genome-wide association study of serious blistering skin rash caused by drugs.","volume":"12","author":"Shen","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"R49-7-20210128","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum Mol Genet"},{"key":"R51-7-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00438-012-0685-9","article-title":"Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.","volume":"287","author":"Shin","year":"2012","journal-title":"Mol Genet Genomics"},{"key":"R52-7-20210128","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1398-9995.2010.02514.x","article-title":"Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics.","volume":"66","author":"Cheong","year":"2011","journal-title":"Allergy"},{"key":"R53-7-20210128","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1365-2222.2009.03229.x","article-title":"Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma.","volume":"39","author":"Sekigawa","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"R54-7-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.smim.2012.11.003","article-title":"3rd, Ribeiro RM, et al. Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.","volume":"25","author":"Arazi","year":"2013","journal-title":"Semin Immunol"},{"key":"R55-7-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2350-12-118","article-title":"Association of HLA-B5801 allele and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.","volume":"12","author":"Somkrua","year":"2011","journal-title":"BMC Med Genet"},{"key":"R56-7-20210128","doi-asserted-by":"crossref","first-page":"D561","DOI":"10.1093\/nar\/gkq973","article-title":"The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored.","volume":"39","author":"Szklarczyk","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"R57-7-20210128","doi-asserted-by":"crossref","first-page":"e1000945","DOI":"10.1371\/journal.pcbi.1000945","article-title":"Finding the Dark Matter in human and yeast protein network prediction and modelling.","volume":"6","author":"Ranea","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"R58-7-20210128","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1398-9995.2009.02101.x","article-title":"A network analysis of the single nucleotide polymorphisms in acute allergic diseases.","volume":"65","author":"Renkonen","year":"2010","journal-title":"Allergy"},{"key":"R59-7-20210128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/JAA.S14459","article-title":"Network analysis of single nucleotide polymorphisms in asthma.","volume":"3","author":"Renkonen","year":"2010","journal-title":"J Asthma Allergy"},{"key":"R60-7-20210128","doi-asserted-by":"crossref","first-page":"D1001","DOI":"10.1093\/nar\/gkt1229","article-title":"The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.","volume":"42","author":"Welter","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"R61-7-20210128","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ajhg.2013.10.012","article-title":"Beyond GWASs: illuminating the dark road from association to function.","volume":"93","author":"Edwards","year":"2013","journal-title":"Am J Hum Genet"},{"key":"R62-7-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome.","volume":"489","author":"Dunham","year":"2012","journal-title":"Nature"},{"key":"R63-7-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature09914","article-title":"Differential microRNA regulation of HLA-C expression and its association with HIV control.","volume":"472","author":"Kulkarni","year":"2011","journal-title":"Nature"},{"key":"R64-7-20210128","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/ng.486","article-title":"HLA-C cell surface expression and control of HIVAIDS correlate with a variant upstream of HLA-C.","volume":"41","author":"Thomas","year":"2009","journal-title":"Nat Genet"},{"key":"R65-7-20210128","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.1174148","article-title":"Common regulatory variation impacts gene expression in a cell type-dependent manner.","volume":"325","author":"Dimas","year":"2009","journal-title":"Science"},{"key":"R66-7-20210128","doi-asserted-by":"crossref","first-page":"e74821","DOI":"10.1371\/journal.pone.0074821","article-title":"Dysregulation of complement system and CD4 T cell activation pathways implicated in allergic response.","volume":"8","author":"Couto Alves","year":"2013","journal-title":"PLoS One"},{"key":"R67-7-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1744-8069-10-7","article-title":"A comparison of RNA-seq and exon arrays for whole genome transcription profiling of the L5 spinal nerve transection model of neuropathic pain in the rat.","volume":"10","author":"Perkins","year":"2014","journal-title":"Mol Pain"},{"key":"R68-7-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics.","volume":"10","author":"Wang","year":"2009","journal-title":"Nat Rev Genet"},{"key":"R69-7-20210128","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.1246755","article-title":"Genetics driving epigenetics.","volume":"342","author":"Furey","year":"2013","journal-title":"Science"},{"key":"R70-7-20210128","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1182\/blood-2013-05-506386","article-title":"Deep sequencing of the T-cell receptor repertoire in CD8 T-large granular lymphocyte leukemia identifies signature landscapes.","volume":"122","author":"Clemente","year":"2013","journal-title":"Blood"},{"key":"R71-7-20210128","doi-asserted-by":"crossref","first-page":"134ra63","DOI":"10.1126\/scitranslmed.3003656","article-title":"High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.","volume":"4","author":"Wu","year":"2012","journal-title":"Sci Transl Med"},{"key":"R72-7-20210128","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","article-title":"Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.","volume":"114","author":"Robins","year":"2009","journal-title":"Blood"},{"key":"R73-7-20210128","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1101\/gr.092924.109","article-title":"Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing.","volume":"19","author":"Freeman","year":"2009","journal-title":"Genome Res"},{"key":"R74-7-20210128","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/bioinformatics\/btt321","article-title":"Insights into polypharmacology from drug-domain associations.","volume":"29","author":"Moya-Garcia","year":"2013","journal-title":"Bioinforma Oxf Engl"},{"key":"R75-7-20210128","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery.","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"R76-7-20210128","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1039\/b905821b","article-title":"The topology of drug-target interaction networks: implicit dependence on drug properties and target families.","volume":"5","author":"Mestres","year":"2009","journal-title":"Mol Biosyst"},{"key":"R77-7-20210128","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4. 0: shedding new light on drug metabolism.","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"R78-7-20210128","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery.","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"R79-7-20210128","doi-asserted-by":"crossref","first-page":"D401","DOI":"10.1093\/nar\/gkt1207","article-title":"STITCH 4 integration of protein-chemical interactions with user data.","volume":"42","author":"Kuhn","year":"2014","journal-title":"Nucleic Acids Res"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:41:21Z","timestamp":1636562481000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201408000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000076","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}